RADIATION THERAPY ONCOLOGY GROUP RTOG 0926 A PHASE II PROTOCOL FOR PATIENTS WITH STAGE T1 BLADDER CANCER TO EVALUATE SELECTIVE BLADDER PRESERVING TREATMENT BY RADIATION THERAPY CONCURRENT WITH RADIOSENSITIZING CHEMOTHERAPY FOLLOWING A THOROUGH TRANSURETHRAL SURGICAL RE-STAGING

[1]  M. Parmar,et al.  A randomized trial of radical radiotherapy for the management of pT1G3 NXM0 transitional cell carcinoma of the bladder. , 2007, The Journal of urology.

[2]  J. Dunst,et al.  Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy? , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  E. H. Lambert,et al.  The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy , 2007, BJU international.

[4]  J Alfred Witjes,et al.  Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. , 2006, European urology.

[5]  D. Grignon,et al.  Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy. , 2004, Urologic oncology.

[6]  John D. Roberts,et al.  RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy. , 2003, International journal of radiation oncology, biology, physics.

[7]  V. Khoo,et al.  Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy. , 2002, International journal of radiation oncology, biology, physics.

[8]  A. Zietman,et al.  Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. , 2002, Urology.

[9]  W. Murphy,et al.  Risk of continued intravesical therapy and delayed cystectomy in BCG-refractory superficial bladder cancer: an investigational approach. , 2001, Urology.

[10]  W. Fair,et al.  Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  S. Loening,et al.  Superficial bladder cancer: progression and recurrence. , 1983, The Journal of urology.

[12]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .

[13]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[14]  A. Zietman,et al.  Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates--the Massachusetts General Hospital and Radiation Therapy Oncology Group experiences. , 2005, Seminars in radiation oncology.

[15]  D. Cox.  Regression Models and Life-Tables , 1972 .